Clinical Trial Update: Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing two tacrolimus-based immunosuppressive regimens in recipients of marginal donor kidneys has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: KIDNEY TRANSPLANTATION | Phase 3 | Status: COMPLETED